Related references
Note: Only part of the references are listed.Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications
Xiujun Fan et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Pre-eclampsia part 1: current understanding of its pathophysiology
Tinnakorn Chaiworapongsa et al.
NATURE REVIEWS NEPHROLOGY (2014)
Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease
Chiara Marchesi et al.
CARDIOVASCULAR RESEARCH (2013)
Regulator of G-Protein Signaling 5 Controls Blood Pressure Homeostasis and Vessel Wall Remodeling
Vasyl Holobotovskyy et al.
CIRCULATION RESEARCH (2013)
Endothelin-1, Oxidative Stress, and Endogenous Angiotensin II Mechanisms of Angiotensin II Type I Receptor Autoantibody-Enhanced Renal and Blood Pressure Response During Pregnancy
Justin Brewer et al.
HYPERTENSION (2013)
Genetic dissection of the pre-eclampsia susceptibility locus on chromosome 2q22 reveals shared novel risk factors for cardiovascular disease
Matthew P. Johnson et al.
MOLECULAR HUMAN REPRODUCTION (2013)
Inhibition of PPAR gamma during rat pregnancy causes intrauterine growth restriction and attenuation of uterine vasodilation
Natalia I. Gokina et al.
FRONTIERS IN PHYSIOLOGY (2013)
PPARγ Regulates Resistance Vessel Tone Through a Mechanism Involving RGS5-Mediated Control of Protein Kinase C and BKCa Channel Activity
Pimonrat Ketsawatsomkron et al.
CIRCULATION RESEARCH (2012)
The Hyperglycemia and Adverse Pregnancy Outcome Study Associations of GDM and obesity with pregnancy outcomes
Patrick M. Catalano et al.
DIABETES CARE (2012)
Thiazolidinedione safety
Jacqueline Kung et al.
EXPERT OPINION ON DRUG SAFETY (2012)
PDGF-dependent regulation of regulator of G protein signaling-5 expression and vascular smooth muscle cell functionality
Jagadambika J. Gunaje et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Preeclampsia, a Disease of the Maternal Endothelium The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease
Camille E. Powe et al.
CIRCULATION (2011)
Antihypertensive Effects of Peroxisome Proliferator-Activated Receptor-β Activation in Spontaneously Hypertensive Rats
Maria Jose Zarzuelo et al.
HYPERTENSION (2011)
Peroxisome Proliferator-Activated Receptor-γ as a Potential Therapeutic Target in the Treatment of Preeclampsia
Fergus P. McCarthy et al.
HYPERTENSION (2011)
Evidence Implicating Peroxisome Proliferator-Activated Receptor-γ in the Pathogenesis of Preeclampsia
Fergus P. McCarthy et al.
HYPERTENSION (2011)
Association of ATP1B1, RGS5 and SELE polymorphisms with hypertension and blood pressure in African-Americans
Mezbah U. Faruque et al.
JOURNAL OF HYPERTENSION (2011)
Autoantibody-Mediated IL-6-Dependent Endothelin-1 Elevation Underlies Pathogenesis in a Mouse Model of Preeclampsia
Cissy Chenyi Zhou et al.
JOURNAL OF IMMUNOLOGY (2011)
PPARγ and human trophoblast differentiation
Thierry Fournier et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2011)
Animal models of preeclampsia; uses and limitations
F. P. McCarthy et al.
PLACENTA (2011)
RGS2 inhibits β-adrenergic receptor-induced cardiomyocyte hypertrophy
Caroline Nunn et al.
CELLULAR SIGNALLING (2010)
Hypertension in Pregnancy and Later Cardiovascular Risk Common Antecedents?
Pal R. Romundstad et al.
CIRCULATION (2010)
PPARγ in Placental Angiogenesis
Karim Nadra et al.
ENDOCRINOLOGY (2010)
Increased Sensitivity to Angiotensin II Is Present Postpartum in Women With a History of Hypertensive Pregnancy
Aditi R. Saxena et al.
HYPERTENSION (2010)
Does Peroxisome Proliferator-activated Receptor-γ (PPARγ) Protect from Hypertension Directly through Effects in the Vasculature?
Pimonrat Ketsawatsomkron et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Atrap Deficiency Increases Arterial Blood Pressure and Plasma Volume
Mona Oppermann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: Gestational diabetes mellitus, intrauterine growth restriction and preeclampsia
S. J. Holdsworth-Carson et al.
PLACENTA (2010)
Haplotype-based association of regulator of G-protein signaling 5 gene polymorphisms with essential hypertension and metabolic parameters in Chinese
Bing Xiao et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
RGS5, a Hypoxia-inducible Apoptotic Stimulator in Endothelial Cells
Yi Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Regulator of G Protein Signaling 5: A New Player in Vascular Remodeling
Mitah Manzur et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2009)
Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice
Juliana Hamzah et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Juliana Hamzah et al.
NATURE (2008)
Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice
Cissy C. Zhou et al.
NATURE MEDICINE (2008)
G(12)-G(13)-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension
Angela Wirth et al.
NATURE MEDICINE (2008)
Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression
Jeffrey S. Gilbert et al.
HYPERTENSION (2007)
Multiple genes for essential-hypertension susceptibility on chromosome 1q
Yen-Pei Christy Chang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy
Cissy Chenyi Zhou et al.
CIRCULATION RESEARCH (2007)
Major congenital malformations after first-trimester exposure to ACE inhibitors
William O. Cooper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases
R Serreau et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2005)
Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy
LL Waite et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome.: A role in the control of vascular tone and implication for hypertension.
LA Calò et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
An essential role for angiotensin II Type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation
T Saito et al.
FASEB JOURNAL (2003)
Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models
RA Khalil et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2002)
Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure
R Holtwick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness
S AbdAlla et al.
NATURE MEDICINE (2001)
Mild gestational hypertension remote from term: Progression and outcome
JR Barton et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2001)
Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction
M Oelze et al.
CIRCULATION RESEARCH (2000)
Placental peroxisome proliferator-activated receptor-γ is up-regulated by pregnancy serum
LL Waite et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
